NCT01068613 - Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

QAX028

QAX028 60 mcg via inhalation device

DRUG

QAX028

QAX028 20 mcg via inhalation device

DRUG

Tiotropium

Tiotropium via inhalation device

DRUG

Placebo

Placebo to QAX028 via inhalation device

Trial Locations (4)

Advanced Clinical Research Institute, 1211 W. La Palma Ave, Anaheim

Sneeze, Wheeze, & Itch Associates, LLC, 2010 Jacobssen Drive, Normal

Spartanburg Medical Research, 485 Simuel Road, Spartanburg

New Orleans Center for Clinical Research - Knoxville, 1928 Alcoa Highway, Knoxville